Trials of lipid-lowering therapy in primary prevention of coronary heart disease.
作者信息
Jones P H
机构信息
Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
出版信息
Curr Opin Lipidol. 1995 Dec;6(6):365-8. doi: 10.1097/00041433-199512000-00006.
Abstract
The effectiveness of lipid-regulating therapy in the primary prevention of coronary heart disease requires further investigation. The only data available are from trials conducted before the advent of more potent lipid-regulating agents, but several large trials currently in progress are expected to provide valuable evidence about the role of lipid-regulating intervention in primary prevention.
摘要
Zotero 插件